Evidence map›Paper›PMID 34162332›Full record

ArticleBMC ecology and evolution2021

Is mRNA decapping by ApaH like phosphatases present in eukaryotes beyond the Kinetoplastida?

Paula Andrea Castañeda Londoño, Nicole Banholzer, Bridget Bannermann, Susanne Kramer

Open access · goldAbstract read
In one paragraph

Article in BMC ecology and evolution, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. ApaH decaps NpNature chemical biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Eukaryotic mRNA Decapping Activation.Frontiers in genetics · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Paula Andrea Castañeda LondoñoZell- Und Entwicklungsbiologie, Biozentrum, Universität Würzburg, Würzburg, Germany.
Nicole BanholzerZell- Und Entwicklungsbiologie, Biozentrum, Universität Würzburg, Würzburg, Germany.
Bridget BannermannDepartment of Medicine, University of Cambridge, Cambridge, UK.
Susanne KramerZell- Und Entwicklungsbiologie, Biozentrum, Universität Würzburg, Würzburg, Germany. susanne.kramer@uni-wuerzburg.de.ORCID 0000-0002-6302-2560
University of Würzburg · DEUniversity of Cambridge · GB

Funding

Deutsche Forschungsgemeinschaft Kr4017 4-1
6 · The paper itself

Abstract

backgroundApaH like phosphatases (ALPHs) originate from the bacterial ApaH protein and have been identified in all eukaryotic super-groups. Only two of these proteins have been functionally characterised. We have shown that the ApaH like phosphatase ALPH1 from the Kinetoplastid Trypanosoma brucei is the mRNA decapping enzyme of the parasite. In eukaryotes, Dcp2 is the major mRNA decapping enzyme and mRNA decapping by ALPHs is unprecedented, but the bacterial ApaH protein was recently found decapping non-conventional caps of bacterial mRNAs. These findings prompted us to explore whether mRNA decapping by ALPHs is restricted to Kinetoplastida or could be more widespread among eukaryotes.

resultsWe screened 827 eukaryotic proteomes with a newly developed Python-based algorithm for the presence of ALPHs and used the data to characterize the phylogenetic distribution, conserved features, additional domains and predicted intracellular localisation of this protein family. For most organisms, we found ALPH proteins to be either absent (495/827 organisms) or to have non-cytoplasmic localisation predictions (73% of all ALPHs), excluding a function in mRNA decapping. Although, non-cytoplasmic ALPH proteins had in vitro mRNA decapping activity. Only 71 non-Kinetoplastida have ALPH proteins with predicted cytoplasmic localisations. However, in contrast to Kinetoplastida, these organisms also possess a homologue of Dcp2 and in contrast to ALPH1 of Kinetoplastida, these ALPH proteins are very short and consist of the catalytic domain only.

conclusionsALPH was present in the last common ancestor of eukaryotes, but most eukaryotes have either lost the enzyme, or use it exclusively outside the cytoplasm. The acceptance of mRNA as a substrate indicates that ALPHs, like bacterial ApaH, have a wide substrate range: the need to protect mRNAs from unregulated degradation is one possible explanation for the selection against the presence of cytoplasmic ALPH proteins in most eukaryotes. Kinetoplastida succeeded to exploit ALPH as their only or major mRNA decapping enzyme. 71 eukaryotic organisms outside the Kinetoplastid lineage have short ALPH proteins with cytoplasmic localisation predictions: whether these proteins are used as decapping enzymes in addition to Dcp2 or else have adapted to not accept mRNAs as a substrate, remains to be explored.

Indexed as

EukaryotaKinetoplastidaEndoribonucleasesPhosphoric Monoester HydrolasesPhylogenyRNA, MessengerEndoribonucleasesPhosphoric Monoester HydrolasesRNA, MessengerALPHALPH1ApaHApaH like phosphataseKinetoplastidam7G capmRNA capmRNA decappingTrypanosoma brucei

Identifiers

PMID34162332
PMCPMC8220851
OpenAlexW3174242164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.